GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a significant focus in healthcare studies, largely due to its impressive impact on treating ailments such as type 2 diabetes and obesity. New studies have shown that in addition to glucose management, GLP-1 agonists of